angiotensin ii has been researched along with icatibant in 88 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 55 (62.50) | 18.2507 |
2000's | 28 (31.82) | 29.6817 |
2010's | 5 (5.68) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Linz, W; Schölkens, BA | 1 |
Anania, V; Demontis, MP; Glorioso, N; Madeddu, P; Parpaglia, PP; Pisanu, G; Tonolo, G; Troffa, C; Varoni, MV | 1 |
Carretero, OA; Farhy, RD; Ho, KL; Scicli, AG | 2 |
Chen, C; Lokhandwala, MF | 1 |
Bascands, JL; Bompart, G; Girolami, JP; Pecher, C; Rakotoarivony, J; Tack, JL | 1 |
el-Dahr, SS; Yosipiv, IV | 1 |
Hartman, JC | 1 |
Adamiak, D; Kregel, KC; Mott, A; Redlich, T; Stauss, HM; Unger, T; Zhu, YC | 1 |
Chulak, C; Couture, R; Foucart, S | 1 |
Anania, V; Demontis, MP; Fattaccio, MC; Glorioso, N; Madeddu, P; Pinna-Parpaglia, P; Varoni, MV | 1 |
Hjemdahl, P; Kahan, T; Nussberger, J; Schwieler, JH | 2 |
Fox, M; Panchal, BC; Trippodo, NC | 1 |
Bara, AT; Busse, R; Hecker, M; Pörsti, I | 1 |
Abeta, H; Asagami, T; Furukawa, L; Hino, T; Ishii, T; Kushiro, T; Otsuka, Y; Saito, F; Takahashi, A; Tomiyama, H | 1 |
Heitsch, H; Linz, W; Schölkens, BA; Wagner, A; Wiemer, G | 1 |
Demontis, MP; Fattaccio, MC; Glorioso, N; Madeddu, P; Parpaglia, PP; Varoni, MV | 1 |
Bartenbach, S; Gohlke, P; Kuwer, I; Lamberty, V; Linz, W; Schnell, A; Schölkens, BA; Unger, T; Wiemer, G | 1 |
Fior, DR; Fuxe, K; Hedlund, PB | 1 |
Chauvin, B; Giudicelli, JF; Richer, C | 1 |
Allen, GT; Powell, JR; Tesfamariam, B | 1 |
Elghozi, JL; Ponchon, P | 2 |
Chen, K; Dunham, EW; Zhang, X; Zimmerman, BG | 1 |
el-Dahr, SS; Lewis, L; Mitchell, KD; Yosipiv, IV | 1 |
Campbell, SE; Sigusch, HH; Weber, KT | 1 |
Cooper, ME; Komers, R; Rumble, JR | 1 |
Ekelund, U | 1 |
Brosnihan, KB; Chappell, MC; Ferrario, CM; Li, P | 1 |
Abe, K; Kanazawa, M; Kohzuki, M; Sato, T; Yasujima, M; Yoshida, K | 1 |
Endlich, K; Steinhausen, M | 1 |
Allen, TJ; Cao, Z; Cooper, ME; Hulthen, UL; Youssef, S | 1 |
Chen, L; Fändriks, L; Holm, M; Johansson, B; Pettersson, A | 1 |
Benetos, A; Duriez, M; Lacolley, P; Levy, BI; Safar, ME; Taillard, F | 1 |
Diglio, CA; Lancaster, WD; Marsh, JD; Ritchie, RH; Schiebinger, RJ | 1 |
Gohlke, P; Pees, C; Unger, T | 1 |
Chappell, MC; Ferrario, CM; Iyer, SN | 1 |
Heller, J; Horácek, V; Kramer, HJ | 1 |
Arnal, JF; Michel, JB; Pueyo, ME; Rami, J | 1 |
Demeilliers, B; Jover, B; Mimran, A | 1 |
Bomtempo, CA; Campagnole-Santos, MJ; Santos, GF; Santos, RA | 1 |
Angus, JA; Whorlow, SL; Wright, CE | 1 |
El-Dahr, SS; Majid, DS; Navar, LG; Omoro, SA | 1 |
Akashi, K; Asayama, J; Kawahara, A; Keira, N; Kobara, M; Matoba, S; Nakagawa, M; Tatsumi, T | 1 |
Kawachi, H; Kimura, H; Nakamura, T; Obata, J; Ohno, S; Shimizu, F; Yoshida, Y | 1 |
Herizi, A; Jover, B; Mimran, A; Pasquié, JL | 1 |
Agarwal, R | 1 |
Briscoe, TA; Campbell, DJ; Kladis, A; Zhuo, J | 1 |
Avendaño-Vázquez, SE; García-Sáinz, JA | 1 |
Blair-West, JR; Harris, PJ; Rajaratne, AA; Walker, LL | 1 |
Dukacz, SA; Kline, RL | 1 |
Fujiyama, A; Fujiyama, S; Iwasaka, T; Kawada, N; Koyama, Y; Kurihara, H; Masaki, H; Matsubara, H; Miwa, T; Miyazaki, M; Mori, Y; Murasawa, S; Nakagawa, K; Nozawa, Y; Ozono, R; Shibasaki, Y; Takahashi, H; Takai, S; Tanaka, Y; Tsutsumi, Y | 1 |
Hoshi, K; Ichihara, K; Kosugi, T; Nakai, T; Satoh, K | 1 |
De Carvalho, MH; Fortes, ZB; Kosla, MC; Oliveira, MA; Santos, RA | 1 |
Marchini, F; Morazzoni, G; Papp, JG; Parratt, JR; Rastegar, MA; Vegh, A | 1 |
DE Jong, PE; DE Zeeuw, D; Navis, G; Wapstra, FH | 1 |
Gutierez, CI; Israel, A; Sosa, B | 1 |
Datté, JY; Gohlke, P; Pees, C; Ziegler, A | 1 |
Asghar, AU; Bountra, C; Coleman, RA; McQueen, DS; Wheeldon, A | 1 |
Boegehold, MA; Nurkiewicz, TR | 1 |
El Dahr, SS; Majid, DS; Navar, LG; Omoro, SA | 1 |
Catelli De Carvalho, MH; Fernandes, L; Fortes, ZB; Nigro, D; Santos, RA; Tostes, RC | 1 |
Almeida, AP; Ferreira, AJ; Santos, RA | 1 |
Fabiani, ME; Frauman, AG; Johnston, CI; Sourial, M; Thomas, WG | 1 |
Katori, M; Majima, M | 1 |
Fukuda, N; Ikeda, Y; Jin, XQ; Kanmatsuse, K; Lai, YM; Miyazaki, H; Su, JZ; Suzuki, R; Tahira, Y; Takagi, H | 1 |
Asakura, M; Asanuma, H; Funaya, H; Hori, M; Kim, J; Kitakaze, M; Node, K; Ogita, H; Sanada, S; Takashima, S | 1 |
Holstein-Rathlou, NH; Leong, PK; McDonough, AA; Yang, LE; Zhang, Y | 1 |
Benzoni, D; Liu, KL; Lo, M; Sarkis, A | 1 |
Epelde, F; Heras, M; Pérez-Villa, F; Rigol, M; Roig, E; Roqué, M; Sanz, G; Solanes, N | 1 |
Gironacci, MM; Gorzalczany, S; Peña, C; Taira, C; Yujnovsky, I | 1 |
Hiyoshi, H; Okamoto, H; Takano, M; Yayama, K | 1 |
Accorsi-Mendonça, D; Corrêa, FM; Oliveira, AM | 1 |
Adam, A; Bawolak, MT; Fortin, JP; Marceau, F; Vogel, LK | 1 |
Elmarakby, AA; Imig, JD; Pollock, DM; Pollock, JS; Williams, JM | 1 |
Akimitsu, T; Akiyoshi, K; Hara, M; Saikawa, T; Yoshimatsu, H | 1 |
Baber, SR; Fokin, A; Greco, AJ; Kadowitz, PJ; Master, RG | 1 |
Chlopicki, S; Fedorowicz, A; Kozlovski, VI; Lomnicka, M | 1 |
Castro-Chaves, P; Fontes-Carvalho, R; Leite-Moreira, AF; Soares, S | 1 |
Djokic, J; Grbovic, L; Pesic, S; Radenkovic, M | 1 |
Akira, T; Egi, Y; Maruyama, T; Matsumura, Y; Ohkita, M; Sasaoka, T; Takaoka, M; Tawa, M; Yamamoto, A | 1 |
Costa, CA; Criddle, DN; Espinoza, LA; Marins de Carvalho, LC; Ognibene, DT; Oliveira, PR; Resende, AC; Soares de Moura, R; Tano, T | 1 |
Biggi, A; Cabassi, A; De Iaco, G; Iori, M; Magnani, G; Montanari, A; Musiari, L; Novarini, A; Pelà, GM; Pelloni, I; Pinelli, S | 1 |
Alhenc-Gelas, F; Bouby, N; Bruneval, P; Colucci, J; Griol-Charhbili, V; Krege, JH; Mandet, C; Messadi, E; Richer, C; Smithies, O; Vincent, MP | 1 |
Bader, M; Martin, RP; Merino, VF; Nakaie, CR; Oliveira, SM; Pesquero, JB; Rodrigues, ES; Sabatini, RA; Shimuta, SI; Silva, RF | 1 |
Fukui, K; Irie, D; Kato, T; Kawahito, H; Kishida, S; Matsubara, H; Miyagawa, S; Takata, H; Wakana, N; Yamada, H | 1 |
Chong, I; Edward, JA; Feintech, SV; Jones, MR; Jupiter, RC; Kadowitz, PJ; Lasker, GF; Lindsey, SH; Pankey, EA; Peak, TC; Reddy, VG; Yoo, D | 1 |
1 review(s) available for angiotensin ii and icatibant
Article | Year |
---|---|
Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Cardiomegaly; Epoprostenol; Heart; Kallikrein-Kinin System; Nitric Oxide; Renin-Angiotensin System; Reperfusion Injury | 1992 |
1 trial(s) available for angiotensin ii and icatibant
Article | Year |
---|---|
Contribution of bradykinin B2 receptors to the inhibition by valsartan of systemic and renal effects of exogenous angiotensin II in salt-repleted humans.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Bradykinin; Bradykinin B2 Receptor Antagonists; Female; Glomerular Filtration Rate; Humans; Indicators and Reagents; Inulin; Kidney; Male; p-Aminohippuric Acid; Receptor, Bradykinin B2; Renal Circulation; Sodium; Tetrazoles; Valine; Valsartan | 2010 |
86 other study(ies) available for angiotensin ii and icatibant
Article | Year |
---|---|
Effects of Hoe 140, a bradykinin B2-receptor antagonist, on renal function in conscious normotensive rats.
Topics: Acetylcholine; Angiotensin II; Animals; Blood Pressure; Bradykinin; Desoxycorticosterone; Dinoprostone; Endothelins; Kidney; Male; Oligopeptides; Phenylephrine; Rats; Rats, Wistar; Receptors, Bradykinin; Receptors, Neurotransmitter | 1992 |
Kinins mediate the antiproliferative effect of ramipril in rat carotid artery.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Bradykinin; Bridged Bicyclo Compounds; Carotid Arteries; Carotid Artery Injuries; Endothelium, Vascular; Imidazoles; Kinins; Losartan; Male; Muscle, Smooth, Vascular; Oligopeptides; Ramipril; Rats; Rats, Inbred Strains; Tetrazoles | 1992 |
Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Bradykinin; Diuresis; Dopamine Agonists; Drug Synergism; Enalaprilat; Fenoldopam; Glomerular Filtration Rate; Imidazoles; Kidney; Losartan; Male; Natriuresis; Rats; Rats, Sprague-Dawley; Tetrazoles | 1995 |
Bradykinin-induced in vitro contraction of rat mesangial cells via a B2 receptor type.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic beta-2 Receptor Antagonists; Angiotensin II; Animals; Arginine Vasopressin; Bombesin; Bradykinin; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Membrane; Cells, Cultured; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Endothelins; Fatty Acids, Unsaturated; Glomerular Mesangium; Indomethacin; Kinetics; Naphthalenes; Neomycin; Polycyclic Compounds; Prostaglandin Endoperoxides, Synthetic; Protein Kinase C; Quinacrine; Rats; Receptors, Adrenergic, beta-2; Surface Properties; Tetradecanoylphorbol Acetate; Thromboxane A2; Vasoconstrictor Agents | 1994 |
Developmental regulation of ACE gene expression by endogenous kinins and angiotensin II.
Topics: Adrenergic beta-Antagonists; Aging; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aprotinin; Blood Pressure; Bradykinin; Gene Expression Regulation; Kallikreins; Kidney; Kininogens; Kinins; Male; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger | 1995 |
The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors.
Topics: Adrenergic beta-Antagonists; Amino Acid Oxidoreductases; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Heart; Imidazoles; Losartan; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rabbits; Ramipril; Receptors, Angiotensin; Receptors, Bradykinin; Tetrazoles | 1995 |
Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Bradykinin; Disease Models, Animal; Heart; Heart Failure; Hemodynamics; Imidazoles; Isoquinolines; Losartan; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; Tetrahydroisoquinolines; Tetrazoles | 1994 |
Modulatory effect of bradykinin on the release of noradrenaline from rat isolated atria.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Angiotensin II; Animals; Bradykinin; Diclofenac; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Fenoterol; Heart Atria; Indoles; Male; Maleimides; Norepinephrine; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Rats, Wistar | 1995 |
Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.
Topics: Amino Acid Oxidoreductases; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Bradykinin; Carotid Arteries; Imidazoles; Kinins; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Receptors, Bradykinin; Receptors, Neurotransmitter; Tetrazoles; Tunica Intima | 1993 |
Chronic inhibition of bradykinin receptors alters cardiovascular function in rats with an excess of circulating vasoconstrictors.
Topics: Aldosterone; Angiotensin II; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cardiovascular Physiological Phenomena; Corticosterone; Kinins; Rats; Rats, Wistar; Time Factors | 1994 |
Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Diclofenac; Dogs; Electric Stimulation; Female; Norepinephrine; Perfusion; Prostaglandins; Ramipril; Sympathetic Nervous System; Synaptic Transmission; Vasoconstriction | 1994 |
Repression of angiotensin II and potentiation of bradykinin contribute to the synergistic effects of dual metalloprotease inhibition in heart failure.
Topics: Alanine; Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Blood Volume; Bradykinin; Cricetinae; Drug Synergism; Enalaprilat; Heart Failure; Irbesartan; Male; Neprilysin; Tetrazoles; Vasodilation; Ventricular Function, Left | 1995 |
Release of nitric oxide by angiotensin-(1-7) from porcine coronary endothelium: implications for a novel angiotensin receptor.
Topics: Amino Acid Sequence; Angiotensin I; Angiotensin II; Animals; Arginine; Bradykinin; Coronary Vessels; Endothelium, Vascular; In Vitro Techniques; Isoquinolines; Molecular Sequence Data; Muscle Relaxation; Nitric Oxide; Nitroarginine; Peptide Fragments; Receptors, Angiotensin; Swine; Tetrahydroisoquinolines; Vasodilator Agents | 1994 |
Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor.
Topics: Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Glucose; Blood Pressure; Body Weight; Bradykinin; Doxazosin; Enalapril; Glucose Clamp Technique; Hypertension; Imidazoles; Insulin; Kinins; Losartan; Male; Potassium; Rats; Rats, Inbred SHR; Sodium; Tetrazoles | 1994 |
The possible role of angiotensin II subtype AT2 receptors in endothelial cells and isolated ischemic rat hearts.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arginine; Bradykinin; Cattle; Cells, Cultured; Cyclic GMP; Endothelium, Vascular; Female; In Vitro Techniques; Male; Myocardial Ischemia; Nitric Oxide; Nitroarginine; Oligopeptides; Rats; Rats, Wistar; Receptors, Angiotensin | 1993 |
Chronic inhibition of bradykinin B2-receptors enhances the slow vasopressor response to angiotensin II.
Topics: Angiotensin II; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Female; Kinins; Rats; Rats, Wistar; Receptors, Bradykinin | 1994 |
Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate.
Topics: Aging; Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Bradykinin; Cyclic GMP; Dose-Response Relationship, Drug; Female; Hypertension; In Vitro Techniques; Indoles; Maternal-Fetal Exchange; Muscle Contraction; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Perindopril; Pregnancy; Ramipril; Rats; Rats, Inbred SHR; Reference Values; Systole | 1993 |
Autoradiographic evidence for a bradykinin/angiotensin II receptor-receptor interaction in the rat brain.
Topics: Angiotensin II; Animals; Autoradiography; Blood Pressure; Bradykinin; Brain; Brain Chemistry; Iodine Radioisotopes; Male; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Receptors, Bradykinin; Saralasin; Solitary Nucleus | 1993 |
Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Biphenyl Compounds; Blood Pressure; Bradykinin; Diclofenac; Dogs; Epinephrine; Female; Imidazoles; Losartan; Muscle Denervation; Muscles; Norepinephrine; Phenoxybenzamine; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles | 1993 |
Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Decerebrate State; Hemodynamics; Hypertension; Imidazoles; Indoles; Losartan; Male; Muscle, Smooth, Vascular; Perindopril; Rats; Rats, Inbred SHR; Sympathetic Nervous System; Synaptic Transmission; Tetrazoles; Vasoconstriction | 1995 |
Bradykinin B2 receptor-mediated chronotropic effect of bradykinin in isolated guinea pig atria.
Topics: Adrenergic beta-Agonists; Alanine; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Function; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Enzyme Inhibitors; Guinea Pigs; Heart; Heart Atria; Heart Rate; In Vitro Techniques; Kallidin; Male; Myocardium; Nitric Oxide; Prostaglandins; Receptor, Bradykinin B2; Receptors, Bradykinin; Sensitivity and Specificity | 1995 |
[Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Bradykinin; Disease Models, Animal; Heart Rate; Hypertension, Renovascular; Imidazoles; Kallikrein-Kinin System; Losartan; Male; Rats; Receptors, Angiotensin; Renin-Angiotensin System; Signal Processing, Computer-Assisted; Tetrazoles | 1995 |
Kinin-mediated antihypertensive effect of captopril in deoxycorticosterone acetate-salt hypertension.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Blood Pressure; Bradykinin; Captopril; Desoxycorticosterone; Hypertension; Kinins; Male; Nephrectomy; Rats; Rats, Wistar; Reference Values; Renal Circulation; Sodium Chloride; Time Factors | 1996 |
Role of bradykinin B2 receptors in the developmental changes of renal hemodynamics in the neonatal rat.
Topics: Angiotensin II; Animals; Animals, Newborn; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Glomerular Filtration Rate; Hemodynamics; Kidney; Kidney Cortex; p-Aminohippuric Acid; Rats; Rats, Sprague-Dawley; Receptors, Bradykinin; Renal Circulation; Renin; RNA, Messenger; Sodium Chloride | 1995 |
Angiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykinin.
Topics: Angiotensin II; Animals; Arginine; Bradykinin; Bradykinin Receptor Antagonists; Collagen; Cyclooxygenase Inhibitors; Fibrosis; Indomethacin; Male; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Prostaglandins; Rats; Rats, Sprague-Dawley | 1996 |
Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Diabetic Angiopathies; Hypertrophy; Indoles; Kinins; Male; Mesenteric Arteries; Nitric Oxide; Nitroarginine; Perindopril; Rats; Rats, Wistar | 1996 |
Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Heart Rate; Hypertension, Renovascular; Imidazoles; Kallikrein-Kinin System; Losartan; Male; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Tetrazoles | 1996 |
Effects of angiotensin-converting enzyme inhibition on arterial, venous and capillary functions in cat skeletal muscle in vivo.
Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Capillaries; Cats; Enalaprilat; Male; Muscle Tonus; Muscle, Skeletal; Muscle, Smooth, Vascular; Regional Blood Flow; Sympathectomy; Vascular Resistance | 1996 |
Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Drug Synergism; Indomethacin; Male; Peptide Fragments; Vasodilation | 1997 |
Do kinins mediate cardioprotective and renoprotective effects of cilazapril in spontaneously hypertensive rats with renal ablation?
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Cilazapril; Heart Diseases; Kidney; Kidney Diseases; Kidney Failure, Chronic; Kidney Function Tests; Kinins; Nephrectomy; Organ Size; Rats; Rats, Inbred SHR | 1995 |
Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Drug Synergism; Female; Isoquinolines; Kidney; Kinins; Quinapril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Renin-Angiotensin System; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan; Vasodilation | 1997 |
Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Kidney Glomerulus; Male; Organ Size; Ramipril; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 1997 |
ACE inhibition by enalaprilate stimulates duodenal mucosal alkaline secretion via a bradykinin pathway in the rat.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bicarbonates; Bradykinin; Bradykinin Receptor Antagonists; Dose-Response Relationship, Drug; Duodenum; Enalaprilat; Intestinal Mucosa; Male; Rats; Rats, Sprague-Dawley; Receptors, Bradykinin; Stimulation, Chemical | 1997 |
Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Bradykinin; Bradykinin Receptor Antagonists; Collagen; Drug Therapy, Combination; Hemodynamics; Hypertension; Hypertrophy; Imidazoles; Isoquinolines; Male; Quinapril; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Tetrahydroisoquinolines; Tetrazoles | 1997 |
Bradykinin blocks angiotensin II-induced hypertrophy in the presence of endothelial cells.
Topics: Angiotensin II; Animals; Animals, Newborn; Bradykinin; Bradykinin Receptor Antagonists; Cells, Cultured; Endothelium; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Rats; Rats, Sprague-Dawley | 1998 |
AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cerebrovascular Disorders; Cyclic GMP; Hypertension; Imidazoles; Losartan; Male; Minoxidil; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Pyridines; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reference Values | 1998 |
Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Dipeptides; Heart Rate; Hypertension; Kinetics; Lisinopril; Losartan; Male; Neprilysin; Organophosphonates; Peptide Fragments; Peptides, Cyclic; Phenylalanine; Protease Inhibitors; Rats; Rats, Inbred SHR; Renin-Angiotensin System | 1998 |
Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Flow Velocity; Blood Pressure; Bradykinin; Captopril; Dogs; Drug Combinations; Female; Glomerular Filtration Rate; Imidazoles; Kidney Glomerulus; Losartan; Male; Potassium; Sodium; Tetrazoles; Urea; Vascular Resistance; Vasodilation; Water | 1997 |
Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Aorta, Thoracic; Arginine; Bradykinin; Calcium; Calmodulin; Cells, Cultured; Endothelium, Vascular; Losartan; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Oxidants; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sulfonamides | 1998 |
Contrasting renal effects of chronic administrations of enalapril and losartan on one-kidney, one clip hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Diet, Sodium-Restricted; Enalapril; Glomerular Filtration Rate; Hypertension, Renovascular; Kidney; Kinins; Losartan; Male; Rats; Rats, Sprague-Dawley; Renal Circulation; Sodium | 1998 |
Interaction of bradykinin and angiotensin-(1-7) in the central modulation of the baroreflex control of the heart rate.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Animals; Baroreflex; Bradykinin; Bradykinin Receptor Antagonists; Drug Synergism; Heart Rate; Injections, Intraventricular; Male; Peptide Fragments; Rats; Rats, Wistar | 1998 |
Endogenous angiotensin II and bradykinin delay and attenuate the hypotension after N-type calcium channel blockade in conscious rabbits.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Bradykinin; Calcium Channel Blockers; Dose-Response Relationship, Drug; Enalaprilat; Heart Rate; Hypotension; Losartan; Nasopharynx; omega-Conotoxin GVIA; Peptides; Pressoreceptors; Propranolol; Rabbits; Renin-Angiotensin System | 1998 |
Kinin influences on renal regional blood flow responses to angiotensin-converting enzyme inhibition in dogs.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Diet, Sodium-Restricted; Dogs; Enalaprilat; Kidney Cortex; Kidney Medulla; Reference Values; Renal Circulation; Vasodilation | 1999 |
Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Cell Hypoxia; Cells, Cultured; Cilazapril; Creatine Kinase; Cyclic GMP; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Guanidines; Indomethacin; Methylene Blue; Muscle Fibers, Skeletal; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxygen; Rats; Rats, Wistar; Staurosporine; Tetrazoles | 1999 |
Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Bradykinin; Bradykinin Receptor Antagonists; Cilazapril; Collagen; Disease Models, Animal; Glomerulonephritis, Membranoproliferative; Hydralazine; Kidney Failure, Chronic; Male; Proteinuria; Rats; Rats, Wistar; Renal Circulation; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta | 1999 |
Chronic bradykinin infusion and receptor blockade in angiotensin II hypertension in rats.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Disease Models, Animal; Hemodynamics; Hypertension; Kidney; Male; Organ Size; Potassium; Rats; Rats, Sprague-Dawley | 1999 |
Bradykinin and inhibition of angiotensin-converting enzyme in hypertension.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Drug Interactions; Humans; Kidney | 1999 |
Type 2 bradykinin-receptor antagonism does not modify kinin or angiotensin peptide levels.
Topics: Angiotensin II; Angiotensinogen; Animals; Aorta; Autoradiography; Bradykinin; Bradykinin Receptor Antagonists; Data Interpretation, Statistical; Feedback; Fluorometry; In Vitro Techniques; Kidney; Kinins; Lung; Male; Myocardium; Neprilysin; Peptidyl-Dipeptidase A; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Bradykinin; Renin; Time Factors | 1999 |
Activation of bradykinin B2 receptors increases calcium entry and intracellular mobilization in C9 liver cells.
Topics: Angiotensin II; Animals; Bradykinin; Calcium; Cell Line; Enzyme Activation; Kallidin; Liver; Rats; Receptor, Bradykinin B2; Receptors, Bradykinin; Thapsigargin | 1999 |
The effects of angiotensin II on blood perfusion in the rat renal papilla.
Topics: Angiotensin II; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Kidney Medulla; Laser-Doppler Flowmetry; Losartan; Nitroarginine; Nitroprusside; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Regional Blood Flow; Renal Circulation; Ultrasonography | 1999 |
Differing effects of enalapril and losartan on renal medullary blood flow and renal interstitial hydrostatic pressure in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Enalapril; Hydrostatic Pressure; Kidney Medulla; Laser-Doppler Flowmetry; Losartan; Male; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation | 1999 |
Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation.
Topics: Actins; Amiloride; Angiotensin II; Animals; Aorta; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cell Membrane; Cyclic GMP; Endothelium, Vascular; Imidazoles; Kinins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Promoter Regions, Genetic; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Recombinant Fusion Proteins; Tunica Media; Vasoconstriction; Vasodilation | 1999 |
Participation of angiotensin II and bradykinin in contractile function in dog stunned myocardium.
Topics: Adenosine Triphosphate; Anesthesia; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Enalapril; Female; Heart Rate; In Vitro Techniques; Ligation; Male; Myocardial Contraction; Myocardial Reperfusion; Myocardial Stunning; Telmisartan; Time Factors; Ventricular Pressure | 1999 |
Synergistic effect of angiotensin-(1-7) on bradykinin arteriolar dilation in vivo.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Bradykinin; Bradykinin Receptor Antagonists; Drug Synergism; Enalaprilat; Mesenteric Arteries; Nitric Oxide; Peptide Fragments; Prostaglandins; Rats; Rats, Wistar; Receptor, Bradykinin B2; Vasodilation; Vasodilator Agents | 1999 |
The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Arrhythmias, Cardiac; Arterial Occlusive Diseases; Blood Pressure; Bradykinin; Coronary Circulation; Coronary Disease; Dogs; Dose-Response Relationship, Drug; Female; Kidney; Lung; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Neprilysin; Peptidyl-Dipeptidase A; Phenylalanine | 2000 |
Chronic angiotensin II infusion but not bradykinin blockade abolishes the antiproteinuric response to angiotensin-converting enzyme inhibition in established adriamycin nephrosis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Doxorubicin; Injections, Intraperitoneal; Lisinopril; Male; Nephrosis; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Time Factors | 2000 |
Brain AT(2) receptor mediate vasodepressor response to footshocks: role of kinins and nitric oxide.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Brain; Electroshock; Enzyme Inhibitors; Extremities; Heart Rate; Imidazoles; Injections, Intraventricular; Losartan; Male; Nitric Oxide Synthase; Nitroarginine; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptors, Angiotensin | 2000 |
Short treatments of normotensive and hypertensive rats by angiotensin II and nitric oxide inhibitor induce an increase of noradrenaline sensitivity in isolated vena portae preparations.
Topics: Angiotensin II; Animals; Blood Pressure; Bradykinin; Drug Interactions; Ergotamine; Hypertension; In Vitro Techniques; Male; Minoxidil; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Portal Vein; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasoconstriction | 2000 |
Hoe 140 and pseudo-irreversible antagonism in the rat vas deferens in vitro.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Animals; Bradykinin; Bradykinin Receptor Antagonists; Dose-Response Relationship, Drug; Electric Stimulation; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Norepinephrine; Rats; Rats, Wistar; Vas Deferens | 2000 |
Reinforcement of arteriolar myogenic activity by endogenous ANG II: susceptibility to dietary salt.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arterioles; Blood Pressure; Bradykinin; Diet, Sodium-Restricted; Losartan; Male; Microcirculation; Muscle, Skeletal; Muscle, Smooth, Vascular; Rats; Rats, Inbred WKY; Saralasin; Sodium, Dietary | 2000 |
Roles of ANG II and bradykinin in the renal regional blood flow responses to ACE inhibition in sodium-depleted dogs.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Bradykinin; Diet, Sodium-Restricted; Dogs; Laser-Doppler Flowmetry; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation; Sodium; Tetrazoles | 2000 |
Potentiation of bradykinin by angiotensin-(1-7) on arterioles of spontaneously hypertensive rats studied in vivo.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterioles; Bradykinin; Drug Synergism; Hypertension; Male; Mesenteric Arteries; Peptide Fragments; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasodilation | 2001 |
Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion.
Topics: Angiotensin I; Angiotensin II; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bradykinin; Heart Ventricles; In Vitro Techniques; Indomethacin; Male; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; NG-Nitroarginine Methyl Ester; Peptide Fragments; Rats; Rats, Wistar | 2001 |
Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia.
Topics: Analysis of Variance; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Captopril; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Imidazoles; Losartan; Male; Norepinephrine; Oligopeptides; Prostate; Prostatic Hyperplasia; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Sympathetic Nervous System; Synaptic Transmission | 2001 |
Effect of chronic blockade of the kallikrein-kinin system on the development of hypertension in rats.
Topics: Angiotensin II; Animals; Blood Pressure; Bradykinin; Desoxycorticosterone; Hypertension; Kallikrein-Kinin System; Rats; Rats, Inbred BN; Sodium Chloride, Dietary | 2001 |
Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Arginine; Bradykinin; Bradykinin Receptor Antagonists; Cell Division; Cells, Cultured; DNA; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Gene Expression; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Transfection | 2002 |
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers synergistically increase coronary blood flow in canine ischemic myocardium: role of bradykinin.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Coronary Circulation; Coronary Vessels; Dogs; Drug Synergism; Imidazoles; Myocardial Ischemia; NG-Nitroarginine Methyl Ester; Nitric Oxide; Receptors, Angiotensin; Tetrazoles; Thiazepines; Vasodilation | 2002 |
Diuretic response to acute hypertension is blunted during angiotensin II clamp.
Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Captopril; Diuresis; Drug Synergism; Hypertension; Kidney; Lithium; Male; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2 | 2002 |
Angiotensin II and renal medullary blood flow in Lyon rats.
Topics: Angiotensin II; Animals; Bradykinin; Bradykinin Receptor Antagonists; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Hypertension; Indomethacin; Kidney Medulla; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Rats; Rats, Inbred Strains; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptors, Angiotensin; Reference Values; Renal Circulation; Vasoconstrictor Agents | 2003 |
Enalaprilat, losartan and LU 135252 in coronary blood flow regulation.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bradykinin; Coronary Circulation; Enalaprilat; Female; Losartan; Male; Phenylpropionates; Pyrimidines; Swine | 2003 |
Angiotensin-(1-7) inhibits the angiotensin II-enhanced norepinephrine release in coarcted hypertensive rats.
Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Aortic Coarctation; Bradykinin; Hypertension; Hypothalamus; Imidazoles; In Vitro Techniques; Nitric Oxide; Norepinephrine; Peptide Fragments; Potassium; Pyridines; Rats; Rats, Wistar | 2004 |
Stimulation of cyclic GMP production via AT2 and B2 receptors in the pressure-overloaded aorta after banding.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Valve Stenosis; Bradykinin; Bradykinin B2 Receptor Antagonists; Cyclic GMP; Hypertension; Imidazoles; Ligation; Losartan; Male; Mice; Mice, Inbred ICR; Models, Animal; Nitric Oxide; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Renin; RNA, Messenger; Up-Regulation; Vasoconstriction | 2004 |
B(2)-receptor modulation of the reactivity to phenylephrine and angiotensin II in the carotid artery of normotensive rats after trandolapril treatment.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Carotid Arteries; Endothelium; In Vitro Techniques; Indoles; Indomethacin; Male; Muscle Contraction; NG-Nitroarginine Methyl Ester; Peptidyl-Dipeptidase A; Phenylephrine; Rats; Rats, Wistar; Receptors, Adrenergic, beta-2 | 2006 |
The bradykinin B2 receptor antagonist icatibant (Hoe 140) blocks aminopeptidase N at micromolar concentrations: off-target alterations of signaling mediated by the bradykinin B1 and angiotensin receptors.
Topics: Angiotensin II; Angiotensin III; Aniline Compounds; Animals; Aorta; Bradykinin; Bradykinin B2 Receptor Antagonists; CD13 Antigens; Dose-Response Relationship, Drug; In Vitro Techniques; Kallidin; Kinetics; Protease Inhibitors; Quinolines; Rabbits; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Receptors, Angiotensin; Recombinant Proteins; Signal Transduction; Vasoconstriction; Vasoconstrictor Agents | 2006 |
Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Bradykinin; Chronic Disease; Cyclic N-Oxides; Dinoprost; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Enalapril; Hydrogen Peroxide; Hypertension; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Bradykinin; Spin Labels; Superoxides; Time Factors | 2007 |
AT1 receptor blockade prevents microvascular dysfunction induced by ischemia/reperfusion injury.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Bradykinin; Capillary Permeability; Cell Adhesion; Leukocyte Rolling; Leukocytes; Losartan; Male; Mesentery; Models, Animal; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Venules; Videotape Recording | 2006 |
Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Carotid Artery, External; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Enalaprilat; Male; Meclofenamic Acid; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilator Agents | 2006 |
On the mechanism of coronary vasodilation induced by angiotensin-(1-7) in the isolated guinea pig heart.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Antihypertensive Agents; Bradykinin; Coronary Vessels; Dose-Response Relationship, Drug; Female; Guinea Pigs; Imidazoles; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Pyridines; Vasodilation | 2007 |
Negative inotropic effect of selective AT2 receptor stimulation and its modulation by the endocardial endothelium.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apamin; Bradykinin; Cardiovascular Agents; Charybdotoxin; Cyclooxygenase Inhibitors; Depression, Chemical; Dose-Response Relationship, Drug; Endocardium; Endothelial Cells; Enzyme Inhibitors; Hydroxocobalamin; Imidazoles; In Vitro Techniques; Indomethacin; Myocardial Contraction; Naphthyridines; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Oligopeptides; Papillary Muscles; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Proadifen; Pyridines; Rabbits; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Time Factors | 2008 |
Analysis of the vasorelaxant action of angiotensin II in the isolated rat renal artery.
Topics: Angiotensin II; Animals; Bradykinin; Imidazoles; In Vitro Techniques; Male; Nitroarginine; Pyridines; Rats; Rats, Wistar; Renal Artery; Vasodilation | 2008 |
Angiotensin II type 2 receptor-mediated inhibition of norepinephrine release in isolated rat hearts.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Animals; Bradykinin; Heart; Imidazoles; In Vitro Techniques; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Oligopeptides; Phenylalanine; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sympathetic Nervous System; Tranexamic Acid; Vasoconstrictor Agents | 2008 |
Angiotensin II-mediated vasodilation is reduced in adult spontaneously hypertensive rats despite enhanced expression of AT2 receptors.
Topics: Acetylcholine; Aging; Angiotensin II; Animals; Blotting, Western; Bradykinin; Gene Expression Regulation; Imidazoles; Losartan; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Peptide Fragments; Pyridines; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 2; Vasodilation | 2009 |
Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia.
Topics: Amides; Angiotensin I; Angiotensin II; Animals; Apoptosis; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Fumarates; Heart; Kinins; Lung; Mice; Mice, Mutant Strains; Myocardial Infarction; Myocardial Ischemia; Myocardium; Peptidyl-Dipeptidase A; Renin; Reperfusion Injury | 2010 |
Evidence that kinin B2 receptor expression is upregulated by endothelial overexpression of B1 receptors.
Topics: Acetylcholinesterase; Angiotensin II; Animals; Aorta; Bradykinin; Bradykinin B1 Receptor Antagonists; Endothelium, Vascular; Gene Expression Regulation; In Vitro Techniques; Indomethacin; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Angiotensin, Type 1; Receptor, Bradykinin B1; Receptor, Bradykinin B2; Up-Regulation; Vasodilation | 2013 |
Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin/NO-dependent mechanism.
Topics: Angiotensin II; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Bradykinin; Calcium; Kinins; Macrophages; Mice, Inbred C57BL; Mice, Transgenic; Monocytes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Receptor, Angiotensin, Type 2; Superoxides; Vascular Cell Adhesion Molecule-1 | 2015 |
Analysis of erectile responses to bradykinin in the anesthetized rat.
Topics: Anesthesia; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin B2 Receptor Antagonists; Captopril; Guanylate Cyclase; Male; Nitric Oxide Synthase; Penile Erection; Penis; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Soluble Guanylyl Cyclase; Vasodilator Agents | 2015 |